Patents by Inventor Gerd Michael MUNZERT

Gerd Michael MUNZERT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATMENT OF SOLID MALIGNANCIES INCLUDING ADVANCED OR METASTATIC SOLID MALIGNANCIES
    Publication number: 20190290652
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof for treating patients suffering from solid malignancies including advanced or metastatic solid malignancies comprising a high frequency administration of Volasertib according to a specific dosage schedule.
    Type: Application
    Filed: June 13, 2019
    Publication date: September 26, 2019
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea RUDOLPH
  • METHOD FOR TREATMENT OF SOLID MALIGNANCIES INCLUDING ADVANCED OR METASTATIC SOLID MALIGNANCIES
    Publication number: 20160303131
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof for treating patients suffering from solid malignancies including advanced or metastatic solid malignancies comprising a high frequency administration of Volasertib according to a specific dosage schedule.
    Type: Application
    Filed: June 22, 2016
    Publication date: October 20, 2016
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea RUDOLPH
  • METHOD FOR TREATING ACUTE MYELOID LEUKEMIA
    Publication number: 20160243124
    Abstract: The present invention relates to the use of BI 6727 or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) comprising the administration of a high dose of BI 6727 according to a specific dosage schedule, optionally in combination with cytarabine.
    Type: Application
    Filed: May 5, 2016
    Publication date: August 25, 2016
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea Ingrid RUDOLPH
  • Method for treatment of advanced solid tumors
    Patent number: 9370535
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or a hydrate thereof in combination with Cisplatin or Carboplatin or a salt thereof or a hydrate thereof for treating patients suffering from advanced and/or metastatic solid tumors.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: June 21, 2016
    Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tillmann Taube, Gerd Michael Munzert, Dorothea Rudolph
  • METHOD FOR TREATMENT OF SOLID MALIGNANCIES INCLUDING ADVANCED OR METASTATIC SOLID MALIGNANCIES
    Publication number: 20130131069
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof for treating patients suffering from solid malignancies including advanced or metastatic solid malignancies comprising a high frequency administration of Volasertib according to a specific dosage schedule.
    Type: Application
    Filed: May 9, 2012
    Publication date: May 23, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea RUDOLPH
  • METHOD FOR TREATMENT OF ADVANCED SOLID TUMORS
    Publication number: 20130122111
    Abstract: The present invention relates to the use of Volasertib or a salt thereof or a hydrate thereof in combination with Cisplatin or Carboplatin or a salt thereof or a hydrate thereof for treating patients suffering from advanced and/or metastatic solid tumours.
    Type: Application
    Filed: May 9, 2012
    Publication date: May 16, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Tillmann TAUBE, Gerd Michael MUNZERT, Dorothea RUDOLPH